Fujifilm Diosynth Biotechnologies

Fujifilm Diosynth Biotechnologies is owned by Fujifilm Holdings.

Fujifilm Holdings is one of the...

• Forbes Global 2000 (#551);
• Nikkei 225;
• Topix.

Fujifilm Holdings is a company listed under the stock ticker 4901 (JP).

Fujifilm Holdings has a direct presence in 10 countries.

Fujifilm Holdings has 18 subsidiaries including Astra Graphia, Fuji Xerox and Fuji Xerox Australia.

They are in:

• Office Equipment26%
• Medical Equipment16%
• Other58%

View the org chart displaying its 15 main executives

Most searched biographies at Fujifilm Diosynth Biotechnologies

• Lars Petersen, President and Chief Executive Officer
• Toshi Iida, Chairman of the Board
• Gill Raw, General Counsel

Popular executive movements at Fujifilm Diosynth Biotechnologies

• Richard Mcavoy, who was Site Head and Vice President of Business Support, is promoted to Chief Financial Officer  (posted on March 12 2024).
• Maja Pedersen has joined the company as Chief Quality Officer  (posted on October 5 2023).
• Dennis Schmidt Pedersen has joined the company as Chief People Officer  (posted on October 3 2023).

Create your alert
to follow the executive moves at Fujifilm Diosynth Biotechnologies.

Fujifilm Holdings has 2,276 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Fujifilm Diosynth Biotechnologies

• FUJIFILM Diosynth Biotechnologies Expands Manufacturing Agreement with Argenx for Efgartigimod for the Treatment of Severe Autoimmune Diseases
• FUJIFILM Diosynth Biotechnologies Appoints Richard McAvoy as Chief Financial Officer
• FUJIFILM Diosynth Biotechnologies Announces Renewable Energy PPA with Better Energy for Denmark Manufacturing Site
• FUJIFILM Diosynth Biotechnologies and SHL Medical Enter strategic partnership agreement to help meet growing market demand for autoinjector medicines 
• Fujifilm to Invest USD 200 Million to Expand                                                         
• FUJIFILM Diosynth Biotechnologies Announces Leadership Succession Appointment Upon Retirement of Site Head
• FUJIFILM Diosynth Biotechnologies Celebrates Site Unveiling for North Carolina Large-Scale Cell Culture Manufacturing Facility
• FUJIFILM Diosynth Biotechnologies Announces First Tenant for New Manufacturing Facility
• FUJIFILM Diosynth Biotechnologies President and CEO Lars Petersen appoints Dennis Schmidt Pedersen as Chief People Officer
• FUJIFILM Diosynth Biotechnologies President and CEO Lars Petersen appoints Maja Pedersen as Chief Quality Officer
• View more press releases Close

Social media about Fujifilm Diosynth Biotechnologies

• Fujifilm Diosynth Biotechnologies on Wikipedia, Google News & Yahoo Finance
• Fujifilm Diosynth Biotechnologies on LinkedIn, Twitter & YouTube

Contact by email its executives including Lars Petersen

Call Fujifilm Diosynth Biotechnologies at +1 919...

View the org chart

Register to receive your alert

Report an error